Overexpression of TKT in tumor types with faster proliferation rates (e.g., pancreatic and HCC) is usually associated with a poor prognosis, because TKT supports tumor cell growth and survival by enhancing the activity of the PPP, promoting nucleotide synthesis and enhancing cellular antioxidant capacity. Here, TKT is linked to neoplasm.